Alzheimer's & Dementia

Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills. Alzheimer’s is the most common cause of dementia among older adults. Dementia is the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioral abilities to such an extent that it interferes with a person’s daily life and activities.

Alzheimer’s Disease | Definition, Causes, Diagnosis & Treatment

Alzheimer’s Disease (AD) is the most common form of dementia worldwide (60-70% of all dementia cases) and is a progressive neurodegenerative disorder.

What is Dementia?

Differences Between Alzheimer's and Dementia

Alzheimer's Disease Causes

AAM - Genetics of Alzheimer's

Alzheimer's Disease Symptoms

Alzheimer's Disease Diagnosis

Alzheimer's Disease Treatments

AAM - The Search for a Cure to Alzheimer's

Alzheimer's Disease Questions

Alzheimer’s tangles and plaques: what’s the difference?

Alzheimer's Disease Epidemiology

See more featured articles »

Pollution and Alzheimer's

AAM - Air pollution and Alzheimer's

Is Alzheimer's Disease Transmissible?

Diet and Alzheimer's Disease

Types of Alzheimer's Disease

Stem Cell Therapy for Alzheimer's

Alzheimer's and Veganism

Biomarkers for Alzheimer's Disease

Alzheimer's Disease Prevention

Inflammation and Alzheimer's Disease

Integrated PET/MR for Alzheimer’s Disease

Gender and Alzheimer’s Risk

Alzheimer's Disease and Sleep Disruption

Does Herpesvirus Cause Alzheimer's?

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

Can Statins Protect Against Alzheimer’s Disease?

Stress and Alzheimer's Disease

Alzheimer's Disease and the Microbiome

Amyloid Cascade Hypothesis

Omega-3 and Alzheimer’s Disease

Antibody Research and Alzheimer’s Disease

Alzheimer’s Disease and Calcium Supplements

Alzheimer’s Disease and Gingko Biloba

Do Antioxidants Benefit Patients with Alzheimer’s and Parkinson’s?

What Causes Dementia?

Dementia Diagnosis

Dementia Prevention

Dementia Symptoms

Dementia Treatment

Dementia with Lewy Bodies

Bright Light Therapy and Dementia

Aromatherapy for Dementia

Coconut Oil and Dementia

What is Mixed Dementia?

Transcutaneous Electrical Nerve Stimulation for Dementia

Childhood Dementia Causes

Mixed Dementia Prevention and Treatment

Mixed Dementia Symptoms and Diagnosis

Childhood Dementia Signs and Symptoms

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

Parkinson's Compared to Dementia with Lewy Bodies (DLB)

Antidepressants and Dementia: Is There a Link?

Does Depression and Anxiety Increase the Risk of Dementia?

Migraines and Dementia

What are Amyloid Plaques?

Can Happiness Protect You from Dementia?

Mythbusting: Misconceptions in Dementia

Latest Alzheimer's & Dementia News and Research

Portable biosensor device for early detection of chronic kidney disease

A new method for early detection of chronic kidney disease, which affects an estimated 7% of the world’s population, has been shown to have potential to service rural and remote patients and communities with limited medical services.

1 Jul 2022

Scientists prove the “neuroprotective” function of p62 protein in a mouse model

Neurodegenerative diseases like Alzheimer’s and Parkinson’s are defined by pathogenic accumulation of toxic proteins in the brain.

1 Jul 2022

Ischemic stroke risk may be higher after COVID-19 compared to flu or bacterial pneumonia

A new study examined electronic health records for approximately half the population of Denmark, looking for people with a diagnosis of COVID-19 or hospitalized with community-acquired pneumonia.

30 Jun 2022

Study characterizes long-COVID symptoms in hospitalized and non-hospitalized COVID-19 patients

Scientists have provided a detailed overview on the long-term symptoms experienced by COVID-19 patients after initial primary infection with SARS-CoV-2.

30 Jun 2022

Key protein α-synuclein linked to inflammation and Parkinson's disease

Currently, there are no disease modifying therapies for Parkinson's disease that can change the progression of the disease. An international team of scientists led by faculty at the University of Colorado Anschutz Medical Campus is hoping to change that.

30 Jun 2022

Study uncovers new gene that increases Alzheimer's disease risk in women

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia, affecting more than 5.8 million individuals in the U.S. Scientists have discovered some genetic variants that increase the risk for developing Alzheimer's; the most well-known of these for people over the age of 65 is the APOE ε4 allele.

30 Jun 2022

Study of condensates offers new hope for the treatment of neurodegenerative diseases

The Körber European Science Prize 2022, endowed with one million euros, is to be awarded to the British cell biologist Anthony Hyman.

30 Jun 2022

The effects and mechanisms of SARS-CoV-2 on the nervous system

Researchers reviewed the neurologic manifestations associated with SARS-CoV-2.

30 Jun 2022

Study finds more of white matter hyperintensities in postmenopausal women

Women who have gone through menopause may have more of a brain biomarker called white matter hyperintensities than premenopausal women or men of the same age, according to a new study published in the June 29, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 Jun 2022

Brain MRIs and genetics may be used to predict the chances of developing Alzheimer's disease

Simon Fraser University researchers are studying how a combination of genetics and brain MRIs may be used to predict the chances of developing Alzheimer's disease in the future.

29 Jun 2022

Sleep turns out to be a significant factor for maintaining cardiovascular health

Sleep duration is now considered an essential component for ideal heart and brain health. Life's Essential 8™ cardiovascular health score replaces Life's Simple 7™, according to a new Presidential Advisory, Life's Essential 8-;Updating and Enhancing the American Heart Association's Construct on Cardiovascular Health, published today in Circulation, the Association's flagship, peer-reviewed journal.

29 Jun 2022

Determining people with cognitive impairments based on their drawing behaviors

Changes in drawing traits have been reported in people with early-stage cognitive impairments, but most studies have used a single drawing task only.

29 Jun 2022

New machine learning method may improve the identification of genes that cause diseases

A new machine learning method to model gene expression levels might improve the identification of genes that cause human diseases, according to a new study by Penn State College of Medicine researchers.

28 Jun 2022

OpenSAFELY-TPP data is broadly representative of the English population

Researchers evaluated the representativeness of the OpenSAFELY-TPP data to the general English population

28 Jun 2022

SARS-CoV-2 virus undertakes a massive takeover of the body's fat-processing system

The virus that causes COVID-19 undertakes a massive takeover of the body's fat-processing system, creating cellular storehouses of fat that empower the virus to hijack the body's molecular machinery and cause disease.

28 Jun 2022

Antiretroviral drug used to treat HIV ameliorates cognitive deficits in mouse model of Down syndrome

Lamivudine, a commonly-used antiretroviral drug for treating HIV, improves cognition in a mouse model of Down syndrome, according to the findings of a joint new study by researchers at the Centre for Genomic Regulation (CRG) and the IrsiCaixa AIDS Research Institute, a center jointly promoted by the "la Caixa" Foundation and the Department of Health of the Generalitat de Catalunya.

28 Jun 2022

Study elucidates the molecular mechanisms of acetylcholine for learning and memory

Acetylcholine (ACh) is a neuromodulator with a central role in aversive learning-;rapid conditioning to unpleasant smell, taste, or touch.

28 Jun 2022

APOEε4 may confer increased risk for CTE-related neuropathological outcomes among older adults with repetitive head impacts

How could two individuals who both played football for 10 years and developed CTE have different disease severity? How could some individuals develop dementia in their 50's while other never develop dementia at all? Perhaps the answer lies in their genes.

27 Jun 2022

Simple scan can reveal if people are at increased risk of late-life dementia

Late-life dementia is becoming increasingly common in people after 80 years of age.

27 Jun 2022

Canadian Consortium on Neurodegeneration in Aging launches an online program to prevent dementia

Canada's largest dementia research initiative, the Canadian Consortium on Neurodegeneration in Aging (CCNA), has launched an innovative online program that offers older adults the opportunity to increase their knowledge of dementia, improve lifestyle risk factors and engage with researchers.

27 Jun 2022